| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent Number | Patent Expiration | Patented / Exclusive Use | | Celgene | REVLIMID | lenalidomide | 021880 | Dec 27, 2005 | RX |
7,189,740 | Apr 11, 2023 | REVLIMID (LENALIDOMIDE) IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEASET ONE PRIOR THERAPY | | Celgene | REVLIMID | lenalidomide | 021880 | Jun 29, 2006 | RX |
7,189,740 | Apr 11, 2023 | REVLIMID (LENALIDOMIDE) IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEASET ONE PRIOR THERAPY | | Wyeth Pharms Inc | ZOSYN | piperacillin sodium; tazobactam sodium | 050684 | Oct 22, 1993 | RX |
6,900,184 | Apr 14, 2023 | METHOD OF TREATING BACTERIAL INFECTIONS | | Wyeth Pharms Inc | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | 050750 | Feb 24, 1998 | RX |
6,900,184 | Apr 14, 2023 | METHOD OF TREATING BACTERIAL INFECTIONS | | Ferring | DESMOPRESSIN ACETATE | desmopressin acetate | 021795 | May 8, 2008 | RX |
7,022,340 | Apr 30, 2023 | |
|